Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

DarioHealth Corp (DRIO) USD0.0001

Sell:$12.86 Buy:$12.95 Change: $0.18 (1.38%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.18 (1.38%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.18 (1.38%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

DarioHealth Corp. (DarioHealth) is a Digital Therapeutics (DTx) company. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology to deliver integrated and engaging digital therapeutics interventions. The DTx products are centered around its users and include the Dario Blood Glucose Monitoring System and the Dario Smart Diabetes Management Solution, which are provided to its users in the form of a smartphone application that enables the delivery of content and periodical evidence-based reports; the DarioEngage platform, which provides support and two-way real-time connectivity between its users and their caregivers, and Dario Intelligence, which utilizes user data and is an analytics tool that can assist healthcare providers in the treatments and predictability of diseases. The Company’s services are available direct to consumers via online marketplaces including Amazon, Walmart, Best Buy and the Google and Apple app stores.

Contact details

142 W. 57th St., 8th Floor
United States
+1 (646) 6654667

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$208.18 million
Shares in issue:
16.51 million
Health Care Equipment
United States
US dollar

Key personnel

  • Richard Anderson
    President, General Manager - North America
  • Erez Raphael
    Chief Executive Officer, Director
  • Zvi Ben-David
    Chief Financial Officer, Treasurer, Secretary
  • Dror Bacher
    Chief Operating Officer
  • Chris Chan
    Senior Vice President of Employer Sales
  • Claudia Kraut
    Vice President - Broker and Consultant Partnerships
  • Oded Cohen
    General Manager - MSK

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.